Science
Mechanism of Action
This tripeptide acts as a lipolytic signal peptide, actively delaying lipid accumulation within adipocytes and encouraging their breakdown into fatty acids. Its mechanism involves blocking the pro-lipid accumulation action of linoleic acid. Furthermore, Tripeptide-41 activates the nuclear transcription factor NF-kB, which subsequently stimulates tumor necrosis factor α (TNFα) production to trigger lipolysis. It also reportedly reduces C/EBP, a factor critical for adipocyte differentiation, and elevates cyclic adenosine monophosphate (cAMP) levels in fat cells. Increased cAMP initiates triglyceride hydrolysis, converting triacylglycerides into glycerin and fatty acids, which are then released from adipocytes, leading to a reduction in fat cell size. Beyond its lipolytic actions, research indicates support for skin firmness and elasticity.
Research
Clinical Evidence
Low confidence5%
Transparency
Dusting Analysis
Given that Tripeptide-41 is typically supplied for 'research use only' and is 'not approved for medical, cosmetic, or therapeutic use in humans,' any claims of efficacy in cosmetic products should be viewed with caution. The limited clinical data from a single manufacturer's study on a very small sample size makes it susceptible to being 'dusted' in formulations, implying its inclusion might be more for marketing claims rather than proven efficacy at relevant concentrations.
The Formula
Formulation
Stability
Tripeptide-41 exhibits excellent solubility and stability in aqueous systems, dissolving readily in sterile water or buffer. It has been incorporated into formulations at a pH of 6. For optimal long-term stability, it should be stored tightly sealed and desiccated at -20°C.
Safety
Safety Profile
Specific safety assessments by regulatory bodies such as CIR, SCCS, or FDA are currently unavailable for Tripeptide-41. However, in research applications, it has demonstrated low cytotoxicity and good biocompatibility, with no significant adverse effects reported in cell culture or in-vitro skin model studies. It is important to note that this ingredient is generally supplied for research use only and lacks approval for medical, cosmetic, or therapeutic use in humans.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Tripeptide-41 presents a promising mechanism for lipolysis and skin elasticity in laboratory settings, the critical lack of robust, independent human clinical data and regulatory approval for cosmetic use warrants a cautious approach.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources